31
Views
6
CrossRef citations to date
0
Altmetric
Review article

The ubiquitin‐proteasome system—micro target for macro intervention?

, , &
Pages 5-13 | Received 08 Mar 2005, Accepted 08 Mar 2005, Published online: 10 Jul 2009
 

Abstract

The ubiquitin‐proteasome system is the two sequential labeling and degradation system that accounts for the degradation of 80–90% of all intracellular proteins. Based on the diversity of its substrates, it is integrated in many different biological processes, especially inflammation and cell proliferation. Given the significance of these two processes for primary atherosclerosis and restenosis, the ubiquitin‐proteasome system may be an amendable target in cardiovascular therapy. This review provides background information on the ubiquitin‐proteasome system, currently available data on its involvement in cardiovascular diseases, and a future perspective on the targeted use proteasome inhibitors, including drug‐eluting stents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.